Form 4: Senseonics Holdings CEO Timothy Goodnow Receives Stock Grant

Senseonics Holdings CEO Timothy Goodnow was granted 4,553,551 restricted stock units (RSUs) on May 23, 2024, which vest in installments starting June 15, 2024.

Summary

• On May 23, 2024, Timothy T Goodnow, the President and CEO of Senseonics Holdings, Inc., was granted 4,553,551 restricted stock units (RSUs).
• The RSUs vest in eight equal installments, with the first vesting on June 15, 2024.
• The remaining seven installments vest in six-month increments starting November 15, 2024, contingent upon Goodnow's continuous service with the company.
• Each RSU represents a contingent right to receive one share of Senseonics Holdings' common stock.
• Following the reported transaction, Goodnow beneficially owns 11,902,727 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to positive as it incentivizes management.

Positives

• The RSU grant aligns the CEO's interests with those of the shareholders, incentivizing him to drive long-term value for the company.
• The vesting schedule encourages continued service and commitment from the CEO.

Risks

• The value of the RSUs is dependent on the future performance of Senseonics Holdings' stock price.
• If the CEO leaves the company before the RSUs fully vest, a portion of the grant may be forfeited.

Future Outlook

The document does not contain specific forward-looking statements, but the RSU grant suggests an expectation of continued service and contribution from the CEO.

Industry Context

Stock grants are a common practice in the healthcare and technology industries to incentivize and retain key executives. The size and vesting schedule of the grant are typical considerations for aligning management interests with shareholder value.

Comparison to Industry Standards

• Executive compensation packages in the medical device industry often include a mix of salary, bonus, and equity-based awards like RSUs.
• Companies such as Medtronic, Abbott, and Boston Scientific also utilize similar equity-based compensation strategies to incentivize their executives.
• The vesting schedule of the RSUs is fairly standard, with most companies using multi-year vesting periods to ensure long-term commitment.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the CEO's interests with the company's long-term success.
• Employees may see the grant as a sign of confidence in the company's future.

Key Dates